Related Articles
Anti‑inflammatory drug resistance selects putative cancer stem cells in a cellular model for genetically predisposed colon cancer
Targeting drug resistant stem cells in a human epidermal growth factor receptor‑2‑enriched breast cancer model
Natural phytochemicals as testable therapeutic alternatives for HER‑2‑enriched breast cancer (Review)
Combinatorial prevention of carcinogenic risk in a model for familial colon cancer
Growth inhibitory efficacy of natural products in a model for triple negative molecular subtype of clinical breast cancer (Review)